Literature DB >> 19555137

Warfarin potentiation: a review of the "FAB-4" significant drug interactions.

Linda Thi1, David Shaw, Jennifer Bird.   

Abstract

Warfarin is an anticoagulant with numerous drug-drug interactions. Four significant drug interactions with warfarin are: fluconazole, amiodarone, sulfamethoxazole/trimethoprim, and metronidazole. Potentially life-threatening interactions with these medications are a common occurrence because they have a broad spectrum of indications in elderly individuals. With the increasing number of elderly individuals, who consume a disproportionate number of medications, cautious monitoring for these drug interactions is essential. Drug interactions often are overlooked despite computer alert systems. Careful analysis of each patient's situation will help in evaluating whether the use of a medication is appropriate. Through knowledge of potential mechanisms of interaction, management options such as dose reductions and/or the use of alternative agents should be used in determining the appropriate drug therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555137     DOI: 10.4140/tcp.n.2009.227

Source DB:  PubMed          Journal:  Consult Pharm        ISSN: 0888-5109


  5 in total

Review 1.  Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

Authors:  Sara R Vazquez
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  P450-Based Drug-Drug Interactions of Amiodarone and its Metabolites: Diversity of Inhibitory Mechanisms.

Authors:  Matthew G McDonald; Nicholas T Au; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2015-08-21       Impact factor: 3.922

3.  The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation.

Authors:  Ngoc Ngo; Scott J Brantley; Daniel R Carrizosa; Angela Dm Kashuba; E Claire Dees; David J Kroll; Nicholas H Oberlies; Mary F Paine
Journal:  J Exp Pharmacol       Date:  2010-07

4.  Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.

Authors:  Scott J Brantley; Nicholas H Oberlies; David J Kroll; Mary F Paine
Journal:  J Pharmacol Exp Ther       Date:  2009-11-24       Impact factor: 4.030

5.  Warfarin-amiodarone drug-drug interactions: determination of [I](u)/K(I,u) for amiodarone and its plasma metabolites.

Authors:  M G McDonald; N T Au; A K Wittkowsky; A E Rettie
Journal:  Clin Pharmacol Ther       Date:  2012-03-07       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.